tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

QURE Stock Latest News

uniQure Begins Phase I/IIa Trial for AMT-260 Therapy
Company AnnouncementsuniQure Begins Phase I/IIa Trial for AMT-260 Therapy
1d ago
8K
QURE
uniQure announces first patient dosed in GenTLE Phase I/IIa trial of AMT-260
PremiumThe Fly
uniQure announces first patient dosed in GenTLE Phase I/IIa trial of AMT-260
2d ago
QURE
uniQure N.V. Reports Q3 2024 Progress and Financials
PremiumCompany Announcements
uniQure N.V. Reports Q3 2024 Progress and Financials
17d ago
QURE
uniQure reports Q3 EPS (91c), consensus ($1.01)
PremiumThe Fly
uniQure reports Q3 EPS (91c), consensus ($1.01)
18d ago
QURE
uniQure N.V. (QURE) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
uniQure N.V. (QURE) Q3 Earnings Cheat Sheet
27d ago
QURE
uniQure Initiates Trial for Promising ALS Gene Therapy
PremiumCompany AnnouncementsuniQure Initiates Trial for Promising ALS Gene Therapy
1M ago
8K
QURE
uniQure announces dosing of first patient in Phase I/II trial of AMT-162
Premium
The Fly
uniQure announces dosing of first patient in Phase I/II trial of AMT-162
1M ago
QURE
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
Premium
The Fly
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
1M ago
CVS
EAT
uniQure reinstated with an Outperform at Raymond James
PremiumThe Fly
uniQure reinstated with an Outperform at Raymond James
1M ago
QURE
uniQure Gains FDA Orphan Drug Status for Fabry Disease Therapy
PremiumCompany Announcements
uniQure Gains FDA Orphan Drug Status for Fabry Disease Therapy
2M ago
8K
QURE
uniQure receives Orphan Drug Designation for AMT-191 in Fabry Disease
PremiumThe Fly
uniQure receives Orphan Drug Designation for AMT-191 in Fabry Disease
2M ago
QURE
uniQure treatment of Fabry disease granted orphan designation
PremiumThe Fly
uniQure treatment of Fabry disease granted orphan designation
2M ago
QURE
uniQure Begins Phase I/IIa Trial for Fabry Disease Treatment
PremiumCompany AnnouncementsuniQure Begins Phase I/IIa Trial for Fabry Disease Treatment
3M ago
8K
QURE
uniQure announces dosing of first patient in Phase I/IIa trial of AMT-191
Premium
The Fly
uniQure announces dosing of first patient in Phase I/IIa trial of AMT-191
3M ago
QURE
uniQure COO Pierre Caloz to depart
Premium
The Fly
uniQure COO Pierre Caloz to depart
4M ago
QURE
uniQure anounces restructuring, expects to reduce headcount by 65%
PremiumThe Fly
uniQure anounces restructuring, expects to reduce headcount by 65%
4M ago
QURE
uniQure expects cash to fund operations through end of 2027
PremiumThe Fly
uniQure expects cash to fund operations through end of 2027
4M ago
QURE
uniQure reports Q2 EPS ($1.16), consensus ($1.25)
PremiumThe Fly
uniQure reports Q2 EPS ($1.16), consensus ($1.25)
4M ago
QURE
QURE Earnings this Week: How Will it Perform?
PremiumPre-Earnings
QURE Earnings this Week: How Will it Perform?
4M ago
QURE
Truist healthcare analyst holds an analyst/industry conference call
PremiumThe FlyTruist healthcare analyst holds an analyst/industry conference call
4M ago
WVE
JAZZ
uniQure Advances with Strategic Facility Sale and Partnership Deals
Premium
Company Announcements
uniQure Advances with Strategic Facility Sale and Partnership Deals
4M ago
8K
QURE
uniQure announces closing of sale of manufacturing facility to Genezen
Premium
The Fly
uniQure announces closing of sale of manufacturing facility to Genezen
4M ago
QURE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >